Year: 2021

news_6

Reata Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Bardoxolone Methyl in Chronic Kidney Disease Caused by Alport Syndrome

PLANO, Texas & ZUG, Switzerland--(BUSINESS WIRE)--$RETA--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical...

news_6

Seabury Solutions Deploys Alkym to Assist Korean National Fire Agency in Managing Helicopter Fleet Operations and Maintenance

Alkym® Platform’s Industry-Leading Capabilities to Advance Agency’s Digitization and Automation Initiatives SEJONG-SI, Republic of Korea--(BUSINESS WIRE)--#AsiaPacific--Seabury Solutions, a subsidiary of...